Arega Medical
0728.941.538 · rovalta.com · 26/09/2026
NORMAL SITUATION
Arega Medical
Company — Normal situation.
Financial year 2024 · Closed on 31/12/2024
Net result855,7 k €+807,1 %over 1 year
Revenue4,6 M €+2,9 %over 1 year
Equity-2,7 M €+24,0 %over 1 year
Overview
Identity
Source · BCE/KBOArega Medical is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0728.941.538
- Legal form
- Private limited company
- Contributed capital
- 20 000,00 €
- Latest accounts
- 31/12/2024
Signals
ProfitablePositive cashflowPositive EBITDA
Financials
Source · NBB, 6 filingsTrend over 6 financial years
| 2024 | 2023 | 2022 | 2021 | 2020 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Revenue | 4,6 M € | +2.9% | 4,5 M € | +23.4% | 3,6 M € | -15.6% | 4,3 M € | +496% | 717,7 k € |
| EBITDA | 724,8 k € | +860% | 75,5 k € | +104% | -1,9 M € | -169% | -711,3 k € | -84.2% | -386,2 k € |
| Operating result | 1 M € | +1351% | 71,1 k € | +103% | -2,2 M € | -194% | -750,8 k € | -94.3% | -386,3 k € |
| Net result | 855,7 k € | +807% | -121 k € | +94.7% | -2,3 M € | -186% | -791,4 k € | -94.0% | -408 k € |
| Balance sheet | |||||||||
| Equity | -2,7 M € | +24.0% | -3,6 M € | -3.5% | -3,4 M € | -191% | -1,2 M € | -202% | -391,7 k € |
| Total assets | 2,2 M € | -2.0% | 2,3 M € | -16.4% | 2,7 M € | -15.4% | 3,2 M € | +55.2% | 2,1 M € |
| Cash | – | – | – | 145,4 k € | -13.3% | 167,8 k € | |||
| Debts | 5 M € | -15.4% | 5,9 M € | -5.3% | 6,2 M € | +40.1% | 4,4 M € | +78.0% | 2,5 M € |
| Other | |||||||||
| Workforce | – | 2,4 ETP | -79.7% | 11,8 ETP | +22.9% | 9,6 ETP | +113% | 4,5 ETP | |
Board of directors
Source · NBB, accounts to 31/12/2024Financials
Full financial information
Source · NBB| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 25/06/2019 |
| Closing of the financial year | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 7 months |
| Filing date | 30/07/2025 | 13/08/2024 | 17/10/2023 | 06/10/2022 | 01/07/2021 | 30/06/2020 |
| General meeting | 30/06/2025 | 01/07/2024 | 12/07/2023 | 15/07/2022 | 30/06/2021 | 30/06/2020 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 6 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2024 | 30/06/2025 | 30/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 01/07/2024 | 13/08/2024 | Dutch | |
| Abridged model | 31/12/2022 | 12/07/2023 | 17/10/2023 | Dutch | |
| Abridged model | 31/12/2021 | 15/07/2022 | 06/10/2022 | Dutch | |
| Abridged model | 31/12/2020 | 30/06/2021 | 01/07/2021 | Dutch | |
| Abridged model | 31/12/2019 | 30/06/2020 | 30/06/2020 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/2024Ownership and network
Looking for more information about this company?
Try for freePublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution08/08/2025RUBRIEK EINDE (STOPZETTING, INTREKKING STOPZETTING, NIETIGHEID, GER. AK., GERECHTELIJKE REORGANISATIE, ENZ... - RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Restructuring30/05/2025RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
- Mandates23/12/2024ONTSLAGEN - BENOEMINGEN
- Mandates27/03/2024ONTSLAGEN - BENOEMINGEN
- Mandates27/03/2024ONTSLAGEN - BENOEMINGEN
- Mandates07/03/2022ONTSLAGEN - BENOEMINGEN
- Mandates07/02/2020ONTSLAGEN - BENOEMINGEN
- Other01/07/2019RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2024Annual accounts 2024855,7 k €↑
- 2023Annual accounts 2023-121 k €↑
- 2022Annual accounts 2022-2,3 M €↓
- 2021Annual accounts 2021-791,4 k €↓
- 2020Annual accounts 2020-408 k €↓
- 2019Annual accounts 2019-3,7 k €